WBDR workshop held in Cape Town, South Africa

WBDR workshop held in Cape Town, South Africa

The World Federation of Hemophilia (WFH) hosted a two-day workshop on research and advocacy in Cape Town, South Africa this past October. The event included healthcare providers (HCPs) and hemophilia treatment centre (HTC) representatives from 17 countries in Africa. The aim of the workshop was to foster collaboration and discuss innovative ways to effectively collect, analyze, present, and publish data from the World Bleeding Disorders Registry (WBDR) to support research and advocacy.

Also available in: Français Español

The first day of the WBDR data workshop provided an opportunity for participants to share knowledge, exchange ideas, and collaborate on ways to advance hemophilia care across the region. Sessions from this day also emphasized the value of building national registries and using collected data to shape policies, support research, and advocate for better patient care.

One highlight of the event was a session led by Saliou Diop, MD, from Senegal. He introduced research methodologies and walked participants through the steps of research proposal development. Participants learned about the importance of generating evidence for research, as well as the process involved in publishing scientific articles. Participants collaborated in groups to develop research proposals tailored to their unique regional context, ensuring the initiatives would be feasible and impactful. These proposals focused on improving diagnosis and care for hemophilia patients and reinforcing the importance of cross-border collaboration to tackle shared healthcare challenges.

The second day of the workshop focused on advocacy. It provided participants with the necessary knowledge to effectively advocate for improved hemophilia care in their countries. Participants learned about the various stages of advocacy, from identifying key issues and stakeholders to developing and executing targeted campaigns.

WFH medical board member Emna Gouider, MD, from Tunisia provided participants with valuable insight, emphasizing the importance of using data to support advocacy efforts, and demonstrating, using concrete examples, how evidence-based approaches can influence policy changes and resource allocation for better patient outcomes.

In another engaging group activity, participants worked together to develop an advocacy plan, each addressing a specific challenge related to hemophilia care. Teams created campaigns and mapped out actionable steps to influence decision-makers. The hands-on exercise allowed for insightful discussions and participants collaborated to apply theoretical knowledge in a practical setting, giving them a chance to hone their presenting skills to maximize the impact of making a case to decision-makers.

The level of engagement in the workshop was strong, and the sense of partnership between the participants from different countries was inspiring. The event had collaborative tone throughout, highlighting the power of data-driven decision-making for improvements in care for people with bleeding disorders. This workshop was the start of what it is hoped will be a series of workshops in various regions of the world, with the same goal of fostering collaboration in support of research and advocacy. 

To find out more about the World Bleeding Disorders Registry (WBDR), please click here.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.

Website privacy policy

The WFH USA does not collect personally identifying information about you when you visit our site, unless you choose to provide such information to us. Providing such information is strictly voluntary. This policy is your guide to how we will handle information we learn about you from your visit to our website.

Use of links

Throughout our website, we provide links to other servers which may contain information of interest to our readers. We take no responsibility for, and exercise no control over, the organizations, views, or accuracy of the information contained on other servers. When linking to the WFH USA, we request that you ensure that there are no associated connections for commercial purposes. Any official use of the name WFH USA or the use of its logo needs to be approved by the WFH USA. If you have a link you’d like us to consider adding to our website, please send an email to [email protected] with the subject “Link request.”

Use of text and images

All information, photographs, graphics, and other material on this website are protected by copyright. While users of this website may use the content for personal, non-commercial use, none of the content of this website can be modified, translated, transferred or sold, copied, reproduced, published, or distributed, in whole or in part, without the prior written consent of the WFH USA. To view a copy of the WFH USA’s permissions guidelines, click here.

The WFH USA encourages the dissemination of its information and welcomes proposals on the reprinting, redistribution, and translation of its materials. If you would like to publish information that you find on our website, please send your request to [email protected].

Accessibility

If you have suggestions on how to make the site more accessible, please contact us at [email protected].

Opt-Out or Change Your Contact Information

Our website provides users the opportunity to opt-out of receiving communications from us through a special online form or via the communication they have received. You may, at all times, choose to receive which communications within the organization you can receive or none at all. You may also update your contact information previously provided to us via another online form.

Questions about our policies

If you have any questions about this privacy statement, the practices of this site, or your dealings with this website, you can contact us at [email protected].

Functional Scales

The outcomes of interest collected by the WBDR include demographic characteristics, clinical and treatment-related outcomes, burden of disease outcomes, and patient-reported outcomes.

The WBDR includes five functional scales as part of its extended data set:

WBDR hemophilia data sets

WBDR Minimal Data Set

The WBDR Minimal Data Set (MDS) is a set of data on demographics, diagnosis, symptoms and treatment which are collected on patients participating in the WBDR.

WBDR Extended Data Set

The WBDR Extended Data Set (EDS) is a larger set of data, with more details than the MDS, which includes questions on patient demographics, diagnosis, symptoms, treatment and burden of disease. The EDS can be used by hemophilia treatment centers to collect data on patients participating in the WBDR. The WBDR Extended Data Set (EDS), was added to the database in March 2019.